Clinical Trials Logo

Invasive Carcinoma of the Breast clinical trials

View clinical trials related to Invasive Carcinoma of the Breast.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04569747 Recruiting - Breast Cancer Clinical Trials

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

ADEPT
Start date: January 11, 2021
Phase: Phase 2
Study type: Interventional

This research study is studying a combination of HER2-directed therapies (trastuzumab and pertuzumab) and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer. The study drugs involved in this study are: - A combination of trastuzumab and pertuzumab given as an injection under the skin (PHESGO) - Hormonal (endocrine) Treatment